Women undergoing treatment for ovarian cancer are checked for tumor cells that may have spread to surrounding tissues, but current technologies miss very small metastatic areas. Now a laser microscopy technique is able to identify these regions with great accuracy.
NIBIB-funded biomedical engineers at the Ohio State University (OSU) have demonstrated a new method for delivering an anti-cancer drug in a study that tested the effect in animal models.
Painless skin patch collects fluid to monitor biomarkers to speed up and simplify routine diagnostic testing.
Brain function can be tracked in real-time using a new MRI method that has the potential to shed light on altered neuronal activity in brain diseases.
Macrophages are white blood cells that accumulate in tumors, where they aid cancer progression. Now scientists have identified a surface protein found only on the macrophages residing in tumors, exposing a target for precise tumor treatments.
Paralyzing damage in spinal cord injury is often caused by the zealous immune response to the injury. NIBIB-funded engineers have developed nanoparticles that lure immune cells away from the spinal cord, allowing regeneration that restored spinal cord function in mice.
A new spectroscopic technique reveals that glucose use in live cells provides valuable information about the functional status of cells, tissues, and organs. Shifts in a cell’s use of glucose can signal changes in health and progress of disease.
Four NIBIB grantees are among more than 300 recipients of the prestigious Presidential Early Career Award for Scientists and Engineers announced by President Donald J. Trump on July 2, 2019.
A new deep learning technique constructs better macroscopic medical images of cells and tissues at ultra-fast speeds.
Researchers have developed a new 3D printed device that will make it faster and easier to identify women at risk for premature birth.
